77 related articles for article (PubMed ID: 19372989)
1. Phenotype and function of protective T cell immune responses in HIV.
Betts MR; Harari A
Curr Opin HIV AIDS; 2008 May; 3(3):349-55. PubMed ID: 19372989
[TBL] [Abstract][Full Text] [Related]
2. Role of HIV-1-specific CD4 T cells.
Harari A; Cellerai C; Pantaleo G
Curr Opin HIV AIDS; 2006 Jan; 1(1):22-7. PubMed ID: 19372779
[TBL] [Abstract][Full Text] [Related]
3. T-cell responses in primary HIV-1 infection.
Streeck H; van Bockel D; Kelleher A
Curr Opin HIV AIDS; 2008 Jan; 3(1):52-9. PubMed ID: 19372944
[TBL] [Abstract][Full Text] [Related]
4. Programmed death-1 as a factor in immune exhaustion and activation in HIV infection.
Kaufmann DE; Walker BD
Curr Opin HIV AIDS; 2008 May; 3(3):362-7. PubMed ID: 19372991
[TBL] [Abstract][Full Text] [Related]
5. Viral reservoirs and HIV-specific immunity.
Blankson JN
Curr Opin HIV AIDS; 2006 Mar; 1(2):147-51. PubMed ID: 19372799
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses.
Sáez-Cirión A; Sinet M; Shin SY; Urrutia A; Versmisse P; Lacabaratz C; Boufassa F; Avettand-Fènoël V; Rouzioux C; Delfraissy JF; Barré-Sinoussi F; Lambotte O; Venet A; Pancino G;
J Immunol; 2009 Jun; 182(12):7828-37. PubMed ID: 19494307
[TBL] [Abstract][Full Text] [Related]
7. Probing the possibilities for T-cell-based AIDS vaccines.
Garber DA; Feinberg MB
Curr Opin HIV AIDS; 2006 Jul; 1(4):314-22. PubMed ID: 19372827
[TBL] [Abstract][Full Text] [Related]
8. Correlates of antibody-mediated protection against HIV infection.
Sattentau Q
Curr Opin HIV AIDS; 2008 May; 3(3):368-74. PubMed ID: 19372992
[TBL] [Abstract][Full Text] [Related]
9. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
[TBL] [Abstract][Full Text] [Related]
10. HIV vaccines: can mucosal CD4 T cells be protected?
Mattapallil JJ; Roederer M
Curr Opin HIV AIDS; 2006 Jul; 1(4):272-6. PubMed ID: 19372821
[TBL] [Abstract][Full Text] [Related]
11. The promise and challenge of anti-HIV cellular immunity.
Borrow P; Turnbull EL
Curr Opin HIV AIDS; 2006 Jul; 1(4):277-85. PubMed ID: 19372822
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection.
Turnbull EL; Wong M; Wang S; Wei X; Jones NA; Conrod KE; Aldam D; Turner J; Pellegrino P; Keele BF; Williams I; Shaw GM; Borrow P
J Immunol; 2009 Jun; 182(11):7131-45. PubMed ID: 19454710
[TBL] [Abstract][Full Text] [Related]
13. Wanted: correlates of vaccine-induced protection against simian immunodeficiency virus.
Friedrich TC; Watkins DI
Curr Opin HIV AIDS; 2008 May; 3(3):393-8. PubMed ID: 19372996
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic immunization in HIV infection.
Autran B; Kinloch-de Loes S; Katlama C
Curr Opin HIV AIDS; 2006 Jul; 1(4):323-9. PubMed ID: 19372828
[TBL] [Abstract][Full Text] [Related]
15. Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes.
Kloverpris H; Karlsson I; Bonde J; Thorn M; Vinner L; Pedersen AE; Hentze JL; Andresen BS; Svane IM; Gerstoft J; Kronborg G; Fomsgaard A
AIDS; 2009 Jul; 23(11):1329-40. PubMed ID: 19528789
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of immune parameters before treatment interruption (TI) for CD4+ T-cell count change during TI in HIV infection.
Huang KH; Loutfy MR; Boulet S; Toma E; Tsoukas CM; Bernard NF
Antivir Ther; 2009; 14(3):381-92. PubMed ID: 19474472
[TBL] [Abstract][Full Text] [Related]
17. Narrowed TCR diversity for immunised mice challenged with recombinant influenza A-HIV Env(311-320) virus.
Cukalac T; Moffat JM; Venturi V; Davenport MP; Doherty PC; Turner SJ; Stambas J
Vaccine; 2009 Nov; 27(48):6755-61. PubMed ID: 19744584
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine.
López A; van der Lubbe N; Sánchez-Palomino S; Arnedo M; Nomdedeu M; Castro P; Guilà M; Maleno MJ; García F; Gallart T; Gatell JM; Plana M
Vaccine; 2009 Oct; 27(44):6166-78. PubMed ID: 19712765
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells.
Lécuroux C; Girault I; Boutboul F; Urrutia A; Goujard C; Meyer L; Lambotte O; Chaix ML; Martinez V; Autran B; Sinet M; Venet A; ; ;
AIDS; 2009 Aug; 23(13):1649-58. PubMed ID: 19617814
[TBL] [Abstract][Full Text] [Related]
20. Treatment interruption to boost specific HIV immunity in acute infection.
Kaufmann DE; Walker BD
Curr Opin HIV AIDS; 2007 Jan; 2(1):21-5. PubMed ID: 19372861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
